Results 21 to 30 of about 38,327 (259)

Spontaneous Heparin-Induced Thrombocytopenia Presenting as Concomitant Bilateral Cerebrovascular Infarction and Acute Coronary Syndrome

Cardiovascular Innovations and Applications, 2023
Background: Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies develop without heparin exposure. Case presentation: A 78-year-old man who underwent a successful lumbar laminectomy presented to the
Jong Kun Park, Ilan Vavilin, Jacob Zaemes, Araba Ofosu-Somuah, Raghav Gattani, Camila Sahebi, Alexander G. Truesdell   +6 more
doaj   +1 more source

Contrast-induced acute kidney injury and renal support for acute kidney injury : a KDIGO summary (part 2) [PDF]

, 2013
Acute kidney injury (AKI) is a common and serious problem affecting millions and causing death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes completed the first ever international multidisciplinary clinical practice ...
Kellum, John A, Lameire, Norbert
core   +2 more sources

Heparin-Induced Thrombocytopenia

Journal of the American College of Cardiology, 1998
Heparin-induced thrombocytopenia (HIT) is a potentially serious complication of heparin therapy and is being encountered more frequently in patients with cardiovascular disease as use of anticoagulant therapy becomes more widespread. Our understanding of the pathophysiology of this immune-mediated condition has improved in recent years, with heparin ...
Brieger, David B, Mak, Koon-Hou, Kottke-Marchant, Kandice, Topol, Eric J   +3 more
openaire   +4 more sources

Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™. [PDF]

, 2013
Understanding chemokine interactions with glycosaminoglycans (GAG) is critical as these interactions have been linked to a number of inflammatory medical conditions, such as arthritis and asthma.
Dykstra, Andrew B, Leary, Julie A, Sweeney, Matt D   +2 more
core   +2 more sources

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition

Gynecology Obstetrics & Reproductive Medicine, 2019
Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented.
Yasin Durmuş, Yalin Ay Karyal, Cigdem Kilic, Caner Cakir, Dilek Yuksel, Berna Seyhan, Gokhan Boyraz, Gunsu Kimyon Comert, Taner Turan   +8 more
doaj   +1 more source

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients [PDF]

, 2014
BACKGROUND: Thrombotic events are a common complication of left ventricular assist device placement and warrant prophylactic anticoagulation. Heparin is the most common anticoagulant used for prophylaxis of thrombotic events in left ventricular assist ...
Aesha Shah, Nicholas Tillman, Scott T Benken, Suhuir Dajani, Toby Thomas   +4 more
core   +1 more source

Safety of Needle Electromyography in Critically Ill Patients [PDF]

, 2020
Introduction: To evaluate the safety of needle electromyography (EMG) in critically ill intensive care unit (ICU) patients who are on anticoagulants and have comorbidities that increase the risk of bleeding and infections.
Bollu, Pradeep, Brannagan, Thomas, Digala, Lakshmi, Govindarajan, Raghav, Nagarajan, Elanagan, Yelam, Anudeep   +5 more
core   +2 more sources

Heparin-Induced Thrombocytopenia [PDF]

Journal of Infusion Nursing, 2017
Heparin-induced thrombocytopenia (HIT) is an immune-mediated complication of heparin therapy. The use of heparin to flush some vascular access devices makes HIT a concern for infusion nurses. This article reviews the risk factors for, pathophysiology of, and management of HIT.
openaire   +5 more sources

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center

SAGE Open Medical Case Reports, 2014
Most clinical studies of heparin-induced thrombocytopenia have not included cancer patients who have high risk of thromboembolism, frequent exposure to heparin, and many potential causes of thrombocytopenia other than heparin-induced thrombocytopenia. To
Weixin Wu, Kelly Merriman, Amr Nabaah, Nikhil Seval, Vahid Afshar-Kharghan, Sai-Ching J Yeung   +5 more
doaj   +1 more source

Prevalence of Heparin-Induced Thrombocytopenia in Hospitalized Patients With Antiphospholipid Syndrome or Lupus With Antiphospholipid Antibodies. [PDF]

Am J Med
Tran V, Schmitt A, Kasturi S.
europepmc   +3 more sources